While previous studies investigated survival time only for specific patient groups such as premenopausal breast cancers with/without positive hormone receptors or patient groups who received supportive treatment with chemotherapy and/or hormones, the present study used a more general sample and included demographic factors not previously considered in Vietnam. The gene discussed is NR4A1; the disease is breast carcinoma.